Scarica l'app Stockscreener
4.67
3.32%
0.15
Dopo l'orario di chiusura:
4.67
Precedente Chiudi:
$4.52
Aprire:
$4.49
Volume 24 ore:
318.21K
Relative Volume:
0.42
Capitalizzazione di mercato:
$259.04M
Reddito:
$163.78M
Utile/perdita netta:
$25.88M
Rapporto P/E:
7.1846
EPS:
0.65
Flusso di cassa netto:
$-28.66M
1 W Prestazione:
+0.43%
1M Prestazione:
+0.00%
6M Prestazione:
+31.18%
1 anno Prestazione:
-31.63%
Intervallo 1D:
$4.40
$4.71
Intervallo di 1 settimana:
$4.40
$4.94
Portata 52W:
$2.645
$7.4436
Voyager Therapeutics Inc Stock (VYGR) Company Profile
Nome
Voyager Therapeutics Inc
Settore
Industria
Telefono
857-259-5340
Indirizzo
75 HAYDEN AVENUE, LEXINGTON, MA
Confronta VYGR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VYGR
Voyager Therapeutics Inc
|
4.67 | 250.72M | 163.78M | 25.88M | -28.66M | 0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-02 | Iniziato | Citigroup | Buy |
| 2024-11-29 | Ripresa | Wedbush | Outperform |
| 2024-10-16 | Iniziato | Leerink Partners | Outperform |
| 2024-03-26 | Iniziato | Guggenheim | Buy |
| 2024-03-19 | Iniziato | H.C. Wainwright | Buy |
| 2024-03-07 | Iniziato | Citigroup | Buy |
| 2024-01-02 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-05-10 | Iniziato | Truist | Buy |
| 2023-03-10 | Iniziato | Oppenheimer | Outperform |
| 2021-10-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-02-03 | Downgrade | Wedbush | Outperform → Neutral |
| 2020-12-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-11-10 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | Iniziato | The Benchmark Company | Buy |
| 2020-02-06 | Iniziato | Oppenheimer | Outperform |
| 2018-11-15 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | Ripresa | BTIG Research | Buy |
| 2018-09-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-12 | Downgrade | Evercore ISI | Outperform → In-line |
| 2018-03-12 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-02-02 | Iniziato | Morgan Stanley | Overweight |
| 2017-11-28 | Ripresa | Piper Jaffray | Overweight |
| 2017-10-31 | Iniziato | Robert W. Baird | Outperform |
| 2017-10-27 | Iniziato | Canaccord Genuity | Buy |
| 2017-10-23 | Reiterato | Stifel | Buy |
| 2017-10-12 | Iniziato | Raymond James | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-28 | Ripresa | Stifel | Buy |
Mostra tutto
Voyager Therapeutics Inc Borsa (VYGR) Ultime notizie
Developing predictive dashboards with Voyager Therapeutics Inc. dataWatch List & Consistent Growth Equity Picks - newser.com
Is Voyager Therapeutics Inc. a candidate for recovery playMarket Volume Summary & Stock Portfolio Risk Management - newser.com
What drives Voyager Therapeutics Inc stock priceConsumer Goods Stocks & Free Daily Market Summary and Trend Reports - earlytimes.in
Has Voyager Therapeutics Inc. formed a bullish divergenceWatch List & Free Verified High Yield Trade Plans - newser.com
Multi asset correlation models including Voyager Therapeutics Inc.Gold Moves & High Accuracy Trade Alerts - newser.com
Is Voyager Therapeutics Inc. stock a buy in volatile marketsWeekly Profit Analysis & Technical Buy Zone Confirmations - newser.com
How institutional ownership impacts Voyager Therapeutics Inc. stock2025 Price Targets & Capital Protection Trade Alerts - newser.com
How high can Voyager Therapeutics Inc. stock go2025 Volatility Report & Stock Portfolio Risk Control - newser.com
Is Voyager Therapeutics Inc. stock attractive after correctionEarnings Growth Summary & Technical Pattern Based Buy Signals - newser.com
Using portfolio simulators with Voyager Therapeutics Inc. included2025 Growth vs Value & Free Community Supported Trade Ideas - newser.com
Voyager Therapeutics Advances Alzheimer’s Study with VY7523 - MSN
Voyager Therapeutics Stock Lost 5.1%, Buy Or Wait? - Trefis
Owning 44% shares,institutional owners seem interested in Voyager Therapeutics, Inc. (NASDAQ:VYGR), - Yahoo Finance
Can Voyager Therapeutics Inc. stock hit analyst price targetsProduct Launch & Safe Entry Momentum Tips - fcp.pa.gov.br
How Voyager Therapeutics Inc. stock compares to market leadersJuly 2025 Decliners & AI Driven Price Forecasts - fcp.pa.gov.br
How Voyager Therapeutics Inc. stock benefits from tech adoption2025 Price Targets & Free Community Supported Trade Ideas - Fundação Cultural do Pará
How to recover losses in Voyager Therapeutics Inc. stockJuly 2025 Levels & Real-Time Stock Movement Alerts - newser.com
Voyager Therapeutics Inc Stock Analysis and ForecastMarket Depth Overview & Low Cost Portfolio Ideas - earlytimes.in
Voyager Therapeutics Inc Azioni (VYGR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):